DRUG IN ADHESIVE TRANSDERMAL SYSTEM OF FUROSEMIDE: IN VITRO IN VIVO EVALUATION
DOI:
https://doi.org/10.22159/ijap.2023v15i4.47681Keywords:
Furosemide, Penetration enhancers, Adhesive systems, In vitro permeation, In vivo kineticsAbstract
Objective: The objective of the present work aims to check the effect of penetration enhancers on release kinetics in a novel drug in the adhesive transdermal system of furosemide.
Methods: The adhesive systems were evaluated for pharmacotechnical properties and in vitro permeation of the drug through the excised rat epidermis. Among the DURO-TAKs screened for in vitro permeation studies. The results were quantified using RP-HPLC. The optimized drug in the adhesive system was subjected to in vivo kinetic studies using New Zealand male rabbits. The adhesive systems were further evaluated for tack properties and skin irritation studies.
Results: DURO-TAK 2510 demonstrated a best permeation profile than DURO-TAK 2852. A combination of penetration enhancers was proved to more be efficient than alone, in the case of F9 (IPM: PG 7.5:2.5) maximum permeation of the drug (314.45±5.97 µg/cm2) was observed by the end of the study with a flux of 9.2052±0.33 μg/cm2/h. The optimized drug in the adhesive system was subjected to in vivo kinetic studies using New Zealand male rabbits. The studies confirmed that controlled release of the drug for a prolonged duration with an extended AUC and MRT decreased Cmax in adhesive systems compared to the oral route, which can provide a promising pharmacological effect the in the DIA system compared to the oral route.
Conclusion: The findings in the present study confirmed that drugs in adhesive systems can provide promising results and can enhance both bioavailability and patient compliance with a combination of penetration enhancers in the development of DIA systems.
Downloads
References
Pietra GG, Edwards WD, Kay JM, Rich S, Kernis J, Schloo B. Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. Circulation. 1989;80(5):1198-206. doi: 10.1161/01.cir.80.5.1198, PMID 2805258.
Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G. Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004;43(12 Suppl):5S-12S. doi: 10.1016/j.jacc.2004.02.037, PMID 15194173.
Badesch DB, Abman SH, Ahearn GS, Barst RJ, McCrory DC, Simonneau G. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004 Jul 1;126(1 Suppl):35S-62S. doi: 10.1378/chest.126.1_suppl.35S, PMID 15249494.
National Center for Biotechnology Information. PubChem compound database; CID=340; 2017. Available from: https://pubchem.ncbi.nlm.nih.gov/compind/3340. [Last accessed on 20 Jun 2017]
Jackson EK. Diuretics. In: Hardman JG, Limbird LE. editors. Goodman and Gilman’s, the pharmacological basis of therapeutics. 10th ed. New York: Mcgraw-Hill; 2001. p. 757-87.
Klausner EA, Lavy E, Stepensky D, Cserepes E, Barta M, Friedman M. Furosemide pharmacokinetics and pharmacodynamics following gastroretentive dosage form administration to healthy volunteers. J Clin Pharmacol. 2003 Jul;43(7):711-20. doi: 10.1177/0091270003254575, PMID 12856384.
Antes LM, Fernandez PC. Principles of diuretic therapy. Disease-A-Month. 1998 Jun 1;44(6):254-68. doi: 10.1016/s0011-5029(98)90003-7, PMID 9679501.
Lee MG, Li T, Chiou WL. Effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of furosemide. Biopharm Drug Dispos. 1986 Nov;7(6):537-47. doi: 10.1002/bdd.2510070603, PMID 3828484.
Thomas BJ, Finnin BC. The transdermal revolution. Drug Discov Today. 2004;9(16):697-703. doi: 10.1016/S1359-6446(04)03180-0, PMID 15341783.
Allen LV, Popovich NG, Ansel HC. Ansel’s pharmaceutical dosage forms and drug delivery systems. 9th ed. Philadelphia: Wolters Kluwer and Lippincott Williams & Wilkins; 2005. p. 298-315.
Banerjee S, Chattopadhyay P, Ghosh A, Datta P, Veer V. Aspect of adhesives in transdermal drug delivery systems. Int J Adhes Adhes. 2014 Apr 1;50:70-84. doi: 10.1016/j.ijadhadh.2014.01.001.
Weng W, Quan P, Liu C, Zhao H, Fang L. Design of a drug-in-adhesive transdermal patch for risperidone: effect of drug-additive interactions on the crystallization inhibition and in vitro/in vivo correlation study. J Pharm Sci. 2016 Oct 1;105(10):3153-61. doi: 10.1016/j.xphs.2016.07.003, PMID 27522527.
Karande P, Mitragotri S. Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim Biophys Acta. 2009 Nov 1;1788(11):2362-73. doi: 10.1016/j.bbamem.2009.08.015, PMID 19733150.
Gwak HS, Chun IK. In vitro percutaneous absorption of tenoxicam from pressure-sensitive adhesive matrices across the hairless mouse skin. Arch Pharm Res. 2001 Dec;24(6):578-83. doi: 10.1007/BF02975169, PMID 11794539.
Arellano A, Santoyo S, Martín C, Ygartua P. Influence of propylene glycol and isopropyl myristate on the in vitro percutaneous penetration of diclofenac sodium from Carbopol gels. Eur J Pharm Sci. 1999 Jan;7(2):129-35. doi: 10.1016/s0928-0987(98)00010-4, PMID 9845796.
Mannam R, Yallamalli IM. RP-HPLC method for estimation of furosemide in rabbit plasma. J Chem Pharm Res. 2018;10:1-5.
Liu C, Fang L. Drug in an adhesive patch of zolmitriptan: formulation and in vitro /in vivo correlation. AAPS PharmSciTech. 2015;16(6):1245-53. doi: 10.1208/s12249-015-0303-3. PMID 25771739.
Zhao K, Singh J. In vitro percutaneous absorption enhancement of propranolol hydrochloride through porcine epidermis by terpenes/ethanol. J Control Release. 1999;62(3):359-66. doi: 10.1016/s0168-3659(99)00171-6, PMID 10528073.
Hu Y, Wu YY, Xia XJ, Wu Z, Liang WQ, Gao JQ. Development of drug-in-adhesive transdermal patch for α-asarone and in vivo pharmacokinetics and efficacy evaluation. Drug Deliv. 2011 Jan 1;18(1):84-9. doi: 10.3109/10717544.2010.520350, PMID 20939674.
Draize JH. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 1944;82:377-90.
Nair AB, Kumria R, Al-Dhubiab BE, Attimarad M, Harsha S. Development of the transdermal delivery system of vildagliptin and its comparison with oral therapy. Indian J Pharm Educ Res. 2016 Jan 1;50(1):130-7. doi: 10.5530/ijper.50.1.17.
Hossain MK, Subedi RK, Chun MK, Kim EJ, Moon HS, Choi HK. Formulation and in vitro evaluation of transdermal drug delivery system for galantamine. J Pharm Investig. 2011;41(1):1-7. doi: 10.4333/KPS.2011.41.1.001.
Lei Y, Yang G, Du F, Yi J, Quan L, Liu H. Formulation and evaluation of a drug-in-adhesive patch for transdermal delivery of colchicine. Pharmaceutics. 2022 Oct 21;14(10):2245. doi: 10.3390/pharmaceutics14102245, PMID 36297680.
Pu T, Li X, Sun Y, Ding X, Pan Y, Wang Q. Development of a prolonged-release pramipexole transdermal patch: in vitro and in vivo evaluation. AAPS PharmSciTech. 2017 Apr;18(3):738-48. doi: 10.1208/s12249-016-0555-6, PMID 27245330.
Lal N, Verma N. Development and evaluation of transdermal patches containing carvedilol and effect of penetration enhancer on drug release. Res J Pharm Technol. 2018;11(2):745-52. doi: 10.5958/0974-360X.2018.00140.3.
Miyajima M, Koshika A, Okada J, Ikeda M. Effect of polymer/basic drug interactions on the two-stage diffusion-controlled release from a poly(l-lactic acid) matrix. J Control Release. 1999;61(3):295-304. doi: 10.1016/s0168-3659(99)00149-2, PMID 10477802.
Tank CJ, Kapse GK, Sarvaiya JI. Transdermal drug delivery of fluvastatin sodium: effect of permeation enhancers and pressure sensitive adhesive. J Pharm Res. 2013 May 1;6(5):573-8. doi: 10.1016/j.jopr.2013.03.029.
Jung E, Lee EY, Choi HK, Ban SJ, Choi SH, Kim JS. Development of drug-in-adhesive patch formulations for transdermal delivery of fluoxetine: in vitro and in vivo evaluations. Int J Pharm. 2015 Jun 20;487(1-2):49-55. doi: 10.1016/j.ijpharm.2015.04.012, PMID 25863117.
Taghizadeh SM, Soroushnia A, Mohamadnia F. Preparation and in vitro evaluation of a new fentanyl patch based on functional and non-functional pressure sensitive adhesives. AAPS PharmSciTech. 2010;11(1):278-84. doi: 10.1208/s12249-009-9366-3, PMID 20182829.
Mannam R, Yallamalli IM. Enhanced both in vitro and in vivo kinetics by SLNs induced transdermal system of furosemide: a novel approach. Recent Pat Drug Deliv Formul. 2017 Dec 1;11(3):187-97. doi: 10.2174/1872211311666171129115441, PMID 29189185.
Published
How to Cite
Issue
Section
Copyright (c) 2023 INDIRA MUZIB YALLAMALLI, REVATHI MANNAM, RAMJIAMBEDKAR YELLAMELLI
This work is licensed under a Creative Commons Attribution 4.0 International License.
